Kisunla becomes the third amyloid-clearing Alzheimer's drug approved since 2021. Last year, the FDA approved Eisai and Biogen ...

Over the past few years, the Food and Drug Administration has approved various new treatments for Alzhimer's disease, but are ...

The FDA approved Kisunla, known chemically as ... aren’t yet setup to prescribe the new plaque-targeting Alzheimer’s drugs. First, doctors need to confirm that patients with dementia have ...

New research on tadpoles shows that the FDA-approved drug donepezil induces a reversible torpor-like state in the animals.

A chemist a UAlbany and his son are looking to make a major breakthrough in the world of Alzheimer's prevention. They believe ...

Eli Lilly has been unable to secure an accelerated FDA approval for its anti-amyloid Alzheimer's disease therapy donanemab ... more than 100 patients on the drug, many of them came off the drug ...

USF’s Memory Disorders Clinic fielding requests from patients and their families hoping that Donanemab can slow progressive ...

They used a drug prediction algorithm to predict ... Their top candidate was DNP, which has been approved since 1996 to treat Alzheimer’s. “Interestingly, clinical overdoses of DNP in patients ...

The US FDA has authorised a new test ... has abandoned efforts to commercialise its Alzheimer's therapy Aduhelm (aducanumab), the only drug approved for the disease that targets the amyloid ...

The U.K. regulatory authority approved the Alzheimer's disease drug, Leqembi, last month. But the U.K. cost-effectiveness ...

The study, published in JAMA, analyzed postmortem brain tissue from 15 individuals with Down syndrome aged 43 to 68 years ...

Britain’s drug regulator has authorized the Alzheimer’s drug Leqembi, saying that it’s the first medicine to show some impact ...